Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Galmed Pharmaceuticals Ltd. (GLMD) had Operating Cash Flow per Share of $-11.72 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.31M |
|
-- |
|
-- |
|
$8.51M |
|
$-8.51M |
|
$-1.80M |
|
$-10.31M |
|
$-7.85M |
|
$-10.31M |
|
$-10.31M |
|
$-10.31M |
|
$-7.85M |
|
$-8.51M |
|
$-8.49M |
|
0.54M |
|
0.54M |
|
$-19.12 |
|
$-19.12 |
|
| Balance Sheet Financials | |
$18.63M |
|
-- |
|
-- |
|
$18.63M |
|
$2.85M |
|
-- |
|
-- |
|
$2.85M |
|
$15.78M |
|
$15.78M |
|
$15.78M |
|
0.82M |
|
| Cash Flow Statement Financials | |
$-6.32M |
|
$-3.38M |
|
$9.03M |
|
$4.77M |
|
$4.11M |
|
$-0.66M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-65.32% |
|
-65.32% |
|
-55.34% |
|
-65.32% |
|
$19.18 |
|
$-11.72 |
|
|
Operating Cash Flow per Share |
$-11.72 |